Qube Research & Technologies LTD Scynexis Inc Transaction History
Qube Research & Technologies LTD
- $61.9 Billion
- Q1 2024
A detailed history of Qube Research & Technologies LTD transactions in Scynexis Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 2,584 shares of SCYX stock, worth $5,038. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,584
Previous 5,863
55.93%
Holding current value
$5,038
Previous $13,000
76.92%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding SCYX
# of Institutions
57Shares Held
15.4MCall Options Held
0Put Options Held
12.9K-
Federated Hermes, Inc. Pittsburgh, PA4.21MShares$8.22 Million0.01% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY2.24MShares$4.36 Million0.4% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.69MShares$3.29 Million0.0% of portfolio
-
Avidity Partners Management LP Dallas, TX1.45MShares$2.83 Million0.08% of portfolio
-
Amh Equity LTD660KShares$1.29 Million1.0% of portfolio
About SCYNEXIS INC
- Ticker SCYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 32,651,800
- Market Cap $63.7M
- Description
- SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...